×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Polyp Biopsy Market Share

ID: MRFR/MED/1141-HCR
90 Pages
Kinjoll Dey
October 2025

Polyp Biopsy Market Research Report Information by Type (Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy and Laryngoscopy), Distribution Channel (Online Sales Channels, Retail Pharmacies), End User (Hospitals & Clinics, Diagnostic Centres and Academic & Research Organizations) - Forecast till 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Polyp Biopsy Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Polyp Biopsy Market Share Analysis

The worldwide market must be strategically positioned to suit consumer and healthcare professional demands to discover and cure polyps. Companies in this specialized market utilize several methods to maintain and develop their gut health market share. New biopsy instruments are a priority for polyposis biopsy companies. Surgery and imaging-guided biopsies are examples of accurate, minimally invasive biopsy procedures. Cutting-edge technology enhances diagnosis accuracy and attracts physicians and nurses seeking new solutions. For market share increase, biopsy equipment must be versatile for diverse body areas and polyps. Offering forceps, brushes, and cleaning gadgets helps companies stand out. This diversity lets physicians and nurses choose the optimal instruments for each patient. Companies work hard to produce patient-friendly testing procedures because they recognize how vital it is. Less discomfort, quicker therapy, and less intrusive treatments make patients pleased. Polyposis biopsy firms that improve the diagnostic procedure portray themselves as patient-centered clinicians. Businesses in the polyposis biopsy sector should expand internationally. Changing products to meet international safety standards, fulfilling regional healthcare requirements, and partnering with global vendors make the market more accessible. Companies become global stars when they reach people worldwide. Companies fund medical education because polyposis diagnosis is so specific. Medical workers learn the latest biopsy procedures via training, courses, and instructional resources. Teaching ensures proper biopsy instrument usage and promotes healthcare professional confidence. Collaborating with gastroenterologists helps achieve market share. Smart companies partner with digestive health physicians and nurses. These agreements simplify product feedback, training program improvement, and medical champion network building. The polyposis biopsy market requires tight regulatory compliance. Companies prioritize regional and international regulations to ensure biopsy product safety and efficacy. Dedicated quality assurance creates confidence between healthcare experts and patients, boosting the company's market reputation. Because medical technology changes, goods must continuously be upgraded. Companies invest in research and development to improve polyposis biopsy instruments' accuracy, usability, and performance. Technologically advanced companies lead their industries. Companies intentionally integrate biopsy equipment to digital health platforms since telemedicine is growing. This allows gastroenterologists and primary care doctors to consult remotely. Telemedicine integrates with healthcare delivery changes and grows market share. Option affordability is crucial for market share growth. Companies that increase manufacturing, negotiate favorable prices, and seek financial help programs raise test product costs. Healthcare personnel that desire cost-effective, high-quality solutions benefit from this approach. Support and follow-up following tests boost market share. Companies that provide aftercare guidance, result interpretation, and follow-up consultations satisfy customers. Happy employees are more likely to recommend the firm to their patients, helping it gain and maintain market share.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What would be the polyp biopsy market CAGR during the forecast period of 2022 to 2030?

Polyp biopsy market CAGR would be 8.3% during the forecast period.

Who are the players involved in the polyp biopsy market report?

The players in polyp biopsy report areAngiotech, INRAD Inc., Cardinal Health, Inc., Hologic, Inc., Carefusion Corporation, C.R. Bard, Inc., Olympus, Devicor Medical Products Inc., and DTR Medica.

Name the region to lead the polyp biopsy market.

The Americas would lead the polyp biopsy market.

Mention the polyp biopsy market valuation by 2030.

Polyp biopsy market valuation would be USD 2.8 Billion.

Name the distribution channels included in the polyp biopsy market report.

The distribution channels of polyp biopsy market report are online sales channel and retail pharmacies.

Market Summary

As per MRFR analysis, the Polyp Biopsy Market Size was estimated at 1.83 USD Million in 2024. The Polyp Biopsy industry is projected to grow from 1.95 in 2025 to 3.3 by 2035, exhibiting a compound annual growth rate (CAGR) of 5.47 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Polyp Biopsy Market is poised for growth driven by technological advancements and increasing patient awareness.

  • North America remains the largest market for polyp biopsy procedures, reflecting a robust healthcare infrastructure.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and awareness.
  • Colonoscopy continues to dominate the market, while endoscopy is rapidly gaining traction due to its minimally invasive nature.
  • Key drivers include the rising incidence of colorectal cancer and advancements in diagnostic technologies, which are enhancing screening efforts.

Market Size & Forecast

2024 Market Size 1.83 (USD Million)
2035 Market Size 3.3 (USD Million)
CAGR (2025 - 2035) 5.47%
Largest Regional Market Share in 2024 North America

Major Players

<p>Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), Olympus Corporation (JP), Cook Medical (US), Conmed Corporation (US), Stryker Corporation (US), Fujifilm Holdings Corporation (JP), Hologic (US)</p>

Market Trends

The Polyp Biopsy Market is currently experiencing a notable transformation, driven by advancements in medical technology and an increasing emphasis on early detection of colorectal cancer. As healthcare providers prioritize preventive measures, the demand for polyp biopsy procedures is likely to rise. This shift is further supported by growing awareness among patients regarding the importance of regular screenings. Additionally, the integration of minimally invasive techniques appears to enhance patient outcomes, potentially leading to a broader acceptance of these procedures within clinical settings. Moreover, the Polyp Biopsy Market is influenced by the ongoing development of innovative diagnostic tools and imaging technologies. These advancements may facilitate more accurate identification of polyps, thereby improving the overall efficacy of biopsies. Furthermore, the collaboration between healthcare professionals and technology developers suggests a promising future for the market, as new solutions are tailored to meet the evolving needs of patients and practitioners alike. As the landscape continues to evolve, stakeholders must remain vigilant to adapt to emerging trends and maintain a competitive edge in this dynamic environment.

Technological Advancements

The Polyp Biopsy Market is witnessing a surge in technological innovations, particularly in imaging and diagnostic tools. These advancements are likely to enhance the precision of polyp detection and characterization, thereby improving patient outcomes. As healthcare providers adopt these new technologies, the efficiency and effectiveness of biopsy procedures may increase, leading to a higher demand for such services.

Increased Patient Awareness

There is a growing awareness among patients regarding the significance of early detection of colorectal cancer. This heightened consciousness is likely to drive more individuals to seek regular screenings and biopsies. As patients become more informed about their health, the Polyp Biopsy Market may experience an uptick in demand, as proactive health management becomes a priority.

Minimally Invasive Techniques

The trend towards minimally invasive procedures is becoming increasingly prominent within the Polyp Biopsy Market. These techniques not only reduce recovery times but also minimize patient discomfort. As healthcare providers continue to adopt these methods, it is anticipated that patient acceptance will grow, further propelling the market forward.

Polyp Biopsy Market Market Drivers

Market Growth Projections

The Global Polyp Biopsy Market Industry is poised for substantial growth, with projections indicating a market value of 1.58 USD Billion in 2024 and an anticipated increase to 3.56 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 7.68% from 2025 to 2035, highlighting the increasing demand for polyp biopsy procedures driven by various factors such as rising colorectal cancer incidence, advancements in biopsy techniques, and government initiatives promoting screening.

Growing Geriatric Population

The aging population worldwide is a crucial factor propelling the Global Polyp Biopsy Market Industry. Older adults are at a higher risk for developing colorectal polyps and cancer, leading to an increased need for screening and biopsy procedures. As the global demographic shifts towards an older population, healthcare systems are likely to see a surge in demand for polyp biopsies. This trend is expected to be reflected in market growth, with projections indicating a rise to 3.56 USD Billion by 2035. The correlation between age and cancer incidence underscores the importance of addressing this demographic shift in the context of market expansion.

Advancements in Biopsy Techniques

Technological innovations in biopsy techniques are significantly influencing the Global Polyp Biopsy Market Industry. Enhanced imaging technologies, such as high-definition endoscopy and virtual colonoscopy, improve the accuracy of polyp detection and characterization. These advancements not only facilitate earlier diagnosis but also increase the efficiency of biopsy procedures. As healthcare providers adopt these cutting-edge technologies, the demand for polyp biopsies is likely to surge. This shift towards more sophisticated diagnostic methods aligns with the industry's growth trajectory, as evidenced by the anticipated market expansion to 3.56 USD Billion by 2035.

Increased Awareness and Education

Heightened awareness and education regarding colorectal health are driving factors in the Global Polyp Biopsy Market Industry. Campaigns aimed at educating the public about the risks of colorectal cancer and the importance of early detection have led to increased screening rates. As individuals become more informed about the benefits of polyp biopsies, they are more likely to seek these procedures. This growing awareness is anticipated to contribute to the market's expansion, with estimates suggesting a market value of 1.58 USD Billion in 2024, potentially reaching 3.56 USD Billion by 2035.

Rising Incidence of Colorectal Cancer

The increasing prevalence of colorectal cancer globally is a primary driver for the Global Polyp Biopsy Market Industry. As awareness of the disease rises, more individuals undergo screening procedures, leading to a higher demand for polyp biopsies. According to health statistics, colorectal cancer remains one of the leading causes of cancer-related deaths worldwide. This trend is expected to contribute to the market's growth, with projections indicating that the market will reach 1.58 USD Billion in 2024 and potentially expand to 3.56 USD Billion by 2035, reflecting a compound annual growth rate of 7.68% from 2025 to 2035.

Government Initiatives and Screening Programs

Government initiatives aimed at promoting cancer screening are pivotal in shaping the Global Polyp Biopsy Market Industry. Many countries have implemented national screening programs that encourage early detection of colorectal cancer. These programs often include recommendations for regular colonoscopies, which inherently involve polyp biopsies. As a result, the number of individuals undergoing these procedures is expected to rise, thereby driving market growth. The proactive stance taken by health authorities not only raises awareness but also enhances accessibility to screening services, contributing to the projected market value of 1.58 USD Billion in 2024.

Market Segment Insights

By Application: Colonoscopy (Largest) vs. Endoscopy (Fastest-Growing)

<p>In the Polyp Biopsy Market, the application segment is primarily dominated by colonoscopy procedures, which represent the largest share due to their established role in polyp detection and removal. Endoscopy follows closely, accounting for a significant proportion of the market, driven by increased usage in various gastrointestinal disorders. Surgical procedures and diagnostic testing have a smaller market presence, yet they play crucial roles in specific patient demographics and clinical settings.</p>

<p>Colonoscopy (Dominant) vs. Surgical Procedures (Emerging)</p>

<p>Colonoscopy procedures are recognized as the dominant application in the Polyp Biopsy Market, owing to their efficacy in early detection and preventive care for colorectal cancer. This method provides a direct evaluation of the colon's interior while allowing for simultaneous biopsy collection. On the other hand, surgical procedures represent an emerging value in this segment, often adopted under more complex clinical circumstances. They are essential for cases that require advanced intervention or when polyp removal cannot be performed during routine examinations, thus indicating a growing need for surgical expertise and resources.</p>

By Type of Polyp: Adenomatous Polyp (Largest) vs. Hyperplastic Polyp (Fastest-Growing)

<p>In the Polyp Biopsy Market, the Adenomatous Polyp remains the largest segment, capturing significant attention due to its association with colorectal cancer risk. This type of polyp is detected frequently during routine screenings and dominates the market share, led by increasing awareness around colorectal health. In contrast, the Hyperplastic Polyp is gaining traction and is recognized as the fastest-growing segment, driven by advancements in diagnostic techniques and an increase in the aging population, which tends to have a higher incidence of various polyp types.</p>

<p>Adenomatous Polyp (Dominant) vs. Hyperplastic Polyp (Emerging)</p>

<p>The Adenomatous Polyp is characterized by its precancerous potential, making it a primary focus during screenings and biopsy procedures. This type of polyp can develop into colorectal cancer if not monitored, highlighting the importance of early detection and intervention. On the other hand, the Hyperplastic Polyp, while traditionally considered to be benign, is increasingly recognized for its role in the serrated pathway of colorectal cancer. As awareness and research grow, the Hyperplastic Polyp segment is rapidly gaining significance, driven by continuous advancements in pathology and improved understanding of its implications.</p>

By Method of Biopsy: Endoscopic Biopsy (Largest) vs. Surgical Biopsy (Fastest-Growing)

<p>In the Polyp Biopsy Market, the Endoscopic Biopsy segment has established itself as the largest method, capturing significant market share due to its minimally invasive nature and precise tissue sampling capabilities. Following this, the Surgical Biopsy segment is gaining traction, with an increasing number of clinical applications favoring its thoroughness and accuracy in challenging cases. As such, these methods represent critical aspects of polyp evaluation and management in clinical practice.</p>

<p>Endoscopic Biopsy (Dominant) vs. Surgical Biopsy (Emerging)</p>

<p>Endoscopic Biopsy stands as the dominant method in the Polyp Biopsy Market, offering a less invasive option that allows for real-time visualization during procedures. This method is recognized for its ease of use and safety profile, making it the preferred choice among healthcare professionals. On the other hand, Surgical Biopsy is emerging as a significant alternative, particularly in complex cases where more extensive tissue sampling is necessary. This growing method is fueled by advances in surgical techniques and improved recovery outcomes, solidifying its position as a competitive option in the polyp biopsy landscape.</p>

By End User: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

<p>In the Polyp Biopsy Market, hospitals represent the largest segment, accounting for a significant share due to their extensive resources and ability to perform a wide range of diagnostic procedures. This dominance is driven by the increasing prevalence of colorectal cancer and the high volume of patient referrals for polyp biopsies. Diagnostic laboratories, being specialized facilities, are witnessing rapid growth, attributed to advancements in biopsy technologies and the rising demand for accurate and timely pathology results.</p>

<p>Hospitals: Dominant vs. Diagnostic Laboratories: Emerging</p>

<p>Hospitals serve as the cornerstone of the Polyp Biopsy Market, providing crucial services with advanced imaging technologies and expert pathologists. Their established infrastructure facilitates a high patient throughput, allowing for comprehensive biopsy services. On the other hand, diagnostic laboratories have emerged as pivotal players, driven by increased collaboration with hospitals and outpatient clinics. They leverage innovative techniques and automation to enhance diagnostic accuracy and reduce turnaround times, positioning themselves as vital contributors to the market, particularly in urban areas where access to specialized services is paramount.</p>

Get more detailed insights about Polyp Biopsy Market Research Report – Global Forecast till 2035

Regional Insights

North America : Market Leader in Biopsy Technology

North America continues to lead the Polyp Biopsy Market, holding a significant share of 0.92 in 2024. The region's growth is driven by increasing incidences of colorectal cancer, advancements in biopsy technologies, and supportive healthcare policies. Regulatory bodies are promoting early detection and preventive measures, further boosting demand for polyp biopsies. The integration of innovative technologies in medical devices is also a key catalyst for market expansion. The competitive landscape in North America is robust, with major players like Medtronic, Boston Scientific, and Johnson & Johnson dominating the market. These companies are investing heavily in R&D to enhance their product offerings and maintain their market positions. The presence of advanced healthcare infrastructure and a high prevalence of gastrointestinal disorders contribute to the region's strong market performance. As a result, North America is expected to maintain its leadership in the Polyp Biopsy Market through 2025.

Europe : Emerging Market with Growth Potential

Europe's Polyp Biopsy Market is poised for growth, with a market size of 0.5 in 2024. Factors such as an aging population, rising awareness about colorectal cancer, and advancements in minimally invasive procedures are driving demand. Regulatory frameworks in various European countries are increasingly supportive of innovative medical technologies, which is expected to further enhance market growth. The emphasis on preventive healthcare is also a significant driver for the polyp biopsy market in this region. Leading countries in Europe include Germany, France, and the UK, where healthcare systems are increasingly adopting advanced biopsy technologies. The competitive landscape features key players like Olympus Corporation and Fujifilm Holdings, who are focusing on expanding their product portfolios. The presence of strong healthcare regulations and funding for cancer research is expected to foster a conducive environment for market growth, making Europe a promising region for polyp biopsy advancements.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific region is witnessing a burgeoning Polyp Biopsy Market, with a market size of 0.3 in 2024. Key growth drivers include increasing healthcare expenditure, rising awareness of colorectal cancer, and the adoption of advanced medical technologies. Governments in the region are implementing policies to improve healthcare access and quality, which is expected to further stimulate demand for polyp biopsies. The growing trend of preventive healthcare is also contributing to market expansion in this area. Countries like Japan, China, and India are leading the market, with significant investments in healthcare infrastructure. The competitive landscape is characterized by the presence of both global and local players, including Cook Medical and Hologic. These companies are focusing on innovation and strategic partnerships to enhance their market presence. As the region continues to develop its healthcare capabilities, the polyp biopsy market is expected to grow significantly through 2025.

Middle East and Africa : Emerging Market with Challenges

The Polyp Biopsy Market in the Middle East and Africa is still in its nascent stages, with a market size of 0.11 in 2024. The growth in this region is primarily driven by increasing awareness of colorectal cancer and the need for improved healthcare services. However, challenges such as limited access to advanced medical technologies and varying healthcare regulations across countries may hinder market growth. Governments are beginning to recognize the importance of early detection, which could catalyze future demand for polyp biopsies. Leading countries in this region include South Africa and the UAE, where healthcare systems are gradually adopting advanced biopsy technologies. The competitive landscape is evolving, with both local and international players seeking to establish a foothold. Companies like Conmed Corporation are focusing on expanding their presence in this market. As healthcare infrastructure improves, the polyp biopsy market in the Middle East and Africa is expected to see gradual growth in the coming years.

Key Players and Competitive Insights

The Polyp Biopsy Market is characterized by a dynamic competitive landscape, driven by advancements in technology, increasing prevalence of colorectal cancer, and a growing emphasis on early detection. Major players such as Medtronic (US), Boston Scientific (US), and Olympus Corporation (JP) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through technological advancements, while Boston Scientific (US) emphasizes strategic partnerships to bolster its market reach. Olympus Corporation (JP) is investing in research and development to introduce cutting-edge solutions, thereby shaping the competitive environment through a blend of innovation and collaboration.

Key business tactics within the Polyp Biopsy Market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, fostering competition that drives innovation and improves patient outcomes.

In November 2025, Medtronic (US) announced the launch of a new endoscopic platform designed to improve the accuracy of polyp detection during biopsies. This strategic move is likely to enhance the company's competitive edge by addressing the growing demand for precision in diagnostic procedures. The introduction of this platform not only reinforces Medtronic's commitment to innovation but also positions it favorably against competitors in a rapidly evolving market.

In October 2025, Boston Scientific (US) entered into a partnership with a leading healthcare technology firm to develop AI-driven solutions for polyp detection. This collaboration is significant as it aligns with the increasing trend towards digitalization in healthcare, potentially improving diagnostic accuracy and patient outcomes. By integrating AI into its offerings, Boston Scientific (US) is likely to enhance its product appeal and market share.

In September 2025, Olympus Corporation (JP) unveiled a new line of biopsy forceps that incorporate advanced materials for improved performance. This strategic initiative reflects Olympus's focus on innovation and quality, which may strengthen its position in the market. The introduction of these forceps is expected to meet the rising demand for reliable and efficient biopsy tools, further solidifying Olympus's reputation as a leader in the field.

As of December 2025, current competitive trends in the Polyp Biopsy Market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and innovative solutions that enhance patient care.

Key Companies in the Polyp Biopsy Market market include

Industry Developments

IZI Medical Products, LLC, a major developer of medical devices used in interventional radiology and interventional oncology treatments, has launched the Quick-Core Auto Biopsy Systems for polyp biopsy. The Quick-Core Auto is a portable, fully automatic biopsy devices that enhances the dependability, precision, and quality of IZI's semi-automatic Quick-Core biopsy system.

NeoDynamics AB, a MedTech company focused to improve breast cancer diagnosis and treatment, has announced a collaboration with the Buckinghamshire Healthcare NHS Trust in London for their NeoNavia pulse biopsy device.

 

Future Outlook

Polyp Biopsy Market Future Outlook

<p>The Polyp Biopsy Market is projected to grow at a 5.47% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of colorectal cancer, and rising awareness.</p>

New opportunities lie in:

  • <p>Development of AI-driven diagnostic tools for enhanced accuracy.</p>
  • <p>Expansion of telehealth services for remote biopsy consultations.</p>
  • <p>Investment in minimally invasive biopsy technologies to improve patient outcomes.</p>

<p>By 2035, the Polyp Biopsy Market is expected to be robust, reflecting significant advancements and growth.</p>

Market Segmentation

Polyp Biopsy Market End User Outlook

  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Clinics
  • Research Institutions

Polyp Biopsy Market Application Outlook

  • Colonoscopy
  • Endoscopy
  • Surgical Procedures
  • Diagnostic Testing

Polyp Biopsy Market Type of Polyp Outlook

  • Adenomatous Polyp
  • Hyperplastic Polyp
  • Sessile Serrated Polyp
  • Traditional Serrated Adenoma

Polyp Biopsy Market Method of Biopsy Outlook

  • Endoscopic Biopsy
  • Surgical Biopsy
  • Forceps Biopsy
  • Snare Biopsy

Report Scope

MARKET SIZE 20241.83(USD Million)
MARKET SIZE 20251.95(USD Million)
MARKET SIZE 20353.3(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.47% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledMedtronic (US), Boston Scientific (US), Johnson & Johnson (US), Olympus Corporation (JP), Cook Medical (US), Conmed Corporation (US), Stryker Corporation (US), Fujifilm Holdings Corporation (JP), Hologic (US)
Segments CoveredApplication, Type of Polyp, Method of Biopsy, End User
Key Market OpportunitiesAdvancements in minimally invasive techniques enhance diagnostic accuracy in the Polyp Biopsy Market.
Key Market DynamicsTechnological advancements in biopsy techniques drive market growth and enhance diagnostic accuracy in polyp detection.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What would be the polyp biopsy market CAGR during the forecast period of 2022 to 2030?

Polyp biopsy market CAGR would be 8.3% during the forecast period.

Who are the players involved in the polyp biopsy market report?

The players in polyp biopsy report areAngiotech, INRAD Inc., Cardinal Health, Inc., Hologic, Inc., Carefusion Corporation, C.R. Bard, Inc., Olympus, Devicor Medical Products Inc., and DTR Medica.

Name the region to lead the polyp biopsy market.

The Americas would lead the polyp biopsy market.

Mention the polyp biopsy market valuation by 2030.

Polyp biopsy market valuation would be USD 2.8 Billion.

Name the distribution channels included in the polyp biopsy market report.

The distribution channels of polyp biopsy market report are online sales channel and retail pharmacies.

  1. Definition
    1. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
    2. Overview
    3. Primary Research
    4. Secondary Research
    5. Market Size Estimation
    6. Drivers
    7. Restraints
    8. Opportunities
    9. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    10. Value Chain Analysis
      1. R&D and Designing
      2. Manufacturing
      3. Distribution & Sales
      4. Post-Sales Review
  2. Chapter 6. Global Polyp Biopsy Market, by Type
    1. Overview
    2. Colonoscopy
  3. Market Estimates & Forecast, by Region, 2020-2027
  4. Market Estimates & Forecast, by Country, 2020-2027
    1. Colposcopy-Directed Biopsy
  5. Market Estimates & Forecast, by Region, 2020-2027
  6. Market Estimates & Forecast, by Country, 2020-2027
    1. Esophagogastroduodenoscopy
  7. Market Estimates & Forecast, by Region, 2020-2027
  8. Market Estimates & Forecast, by Country, 2020-2027
    1. Laryngoscopy
  9. Market Estimates & Forecast, by Region, 2020-2027
  10. Market Estimates & Forecast, by Country, 2020-2027
    1.  
  11. Chapter 7. Global Polyp Biopsy Market, by Distribution Channel
    1. Overview
    2. Online Sales Channels
  12. Market Estimates & Forecast, by Region, 2020-2027
  13. Market Estimates & Forecast, by Country, 2020-2027
    1. Retail Pharmacies
  14. Market Estimates & Forecast, by Region, 2020-2027
  15. Market Estimates & Forecast, by Country, 2020-2027
  16. Chapter 8. Global Polyp Biopsy Market, by End User
    1. Overview
    2. Hospitals & Clinics
  17. Market Estimates & Forecast, by Region, 2020-2027
  18. Market Estimates & Forecast, by Country, 2020-2027
    1. Diagnostic Centers
  19. Market Estimates & Forecast, by Region, 2020-2027
  20. Market Estimates & Forecast, by Country, 2020-2027
    1. Academic & Research Organizations
  21. Market Estimates & Forecast, by Region, 2020-2027
  22. Market Estimates & Forecast, by Country, 2020-2027
    1.  
  23. Chapter 10. Global Polyp Biopsy Market, by Region
    1. Overview
    2. Americas
      1. North America
      2. Latin America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia-Pacific
    5. Middle East & Africa
      1. Middle East
      2. Africa
    6. Chapter 11. Company Landscape
    7. Overview
    8. Competitive Analysis
    9. Chapter 12. Company Profile
    10. Angiotech
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    11. Cardinal Health, Inc.
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    12. Carefusion Corporation
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
      6. Key Strategies
    13. C.R. Bard, Inc.
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
      6. Key Strategies
    14. Devicor Medical Products Inc.
      1. Company Overview
      2. Products/Services Offered
      3. Financial overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    15. DTR Medical
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    16. Hologic, Inc.
      1. Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    17. INRAD Inc.
      1. Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    18. Olympus
      1. Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    19. Others
    20. Chapter 13 Appendix
    21. References
    22. Related Reports
    23.  
  24. LIST OF TABLES
  25. Global Polyp Biopsy Market Synopsis, 2020-2027
  26. Global Polyp Biopsy Market Estimates and Forecast, 2020-2027 (USD Million)
  27. Global Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  28. Global Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  29. Global Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  30. Global Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
  31. Americas: Polyp Biopsy Market, by Region, 2020 and 2025
  32. Americas: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  33. Americas: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  34. Americas Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  35. North America: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
  36. North America: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  37. North America: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  38. North Americas Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  39. US: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  40. US: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  41. US: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  42. Canada: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  43. Canada: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  44. Canada: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  45. Latin America: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  46. Latin America: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  47. Latin America: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  48. Europe: Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
  49. Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  50. Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  51. Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  52. Western Europe: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
  53. Western Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  54. Western Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  55. Western Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  56. Eastern Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  57. Eastern Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  58. Eastern Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  59. Asia-Pacific: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
  60. Asia-Pacific: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  61. Asia-Pacific: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  62. Asia-Pacific: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
  63. Middle East & Africa: Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
  64. Middle East & Africa: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
  65. Middle East & Africa: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
  66. Middle East & Africa: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
    1.  
  67. LIST OF FIGURES
  68. Research Process
  69. Market Structure for Global Polyp Biopsy Market
  70. Market Dynamics for Global Polyp Biopsy Market
  71. Global Polyp Biopsy Market Share, by Type, 2020 (%)
  72. Global Polyp Biopsy Market Share, by Type, 2020 (USD Million)
  73. Global Polyp Biopsy Market Share, by Distribution Channel, 2020 (%)
  74. Global Polyp Biopsy Market Share, by Distribution Channel, 2020 (USD Million)
  75. Global Polyp Biopsy Market Share, by End User, 2020 (%)
  76. Global Polyp Biopsy Market Share, by End User, 2020 (USD Million)
  77. Global Polyp Biopsy Market Share, by Region, 2020 (%)
  78. Americas: Polyp Biopsy Market Share, by Region, 2020 (%)
  79. North America: Polyp Biopsy Market Share, by Country, 2020 (%)
  80. Europe: Polyp Biopsy Market Share, by Region, 2020 (%)
  81. Asia-Pacific: Polyp Biopsy Market Share, by Country, 2020 (%)
  82. Middle East & Africa: Polyp Biopsy Market Share, by Region, 2020 (%)
  83. Global Polyp Biopsy Market: Company Share Analysis, 2020 (%)
  84. Angiotech: Key Financials
  85. Angiotech: Segmental Revenue
  86. Angiotech: Regional Revenue
  87. Cardinal Health, Inc.: Key Financials
  88. Cardinal Health, Inc.: Segmental Revenue
  89. Cardinal Health, Inc.: Regional Revenue
  90. Carefusion Corporation: Key Financials
  91. Carefusion Corporation: Segmental Revenue
  92. Carefusion Corporation: Regional Revenue
  93. C.R. Bard, Inc.: Key Financials
  94. C.R. Bard, Inc.: Segmental Revenue
  95. C.R. Bard, Inc.: Regional Revenue
  96. Devicor Medical Products Inc.: Key Financials
  97. Devicor Medical Products Inc.: Segmental Revenue
  98. Devicor Medical Products Inc.: Regional Revenue
  99. DTR Medical: Key Financials
  100. DTR Medical: Segmental Revenue
  101. DTR Medical: Regional Revenue
  102. Hologic, Inc.: Key Financials
  103. Hologic, Inc.: Segmental Revenue
  104. Hologic, Inc.: Regional Revenue
  105. INRAD Inc.: Key Financials
  106. INRAD Inc.: Segmental Revenue
  107. INRAD Inc.: Regional Revenue
  108. Olympus: Key Financials
  109. Olympus: Segmental Revenue
  110. Olympus: Regional Revenue

Polyp Biopsy Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓